InfuSystem Holdings (INFU) Gross Margin (2010 - 2026)

InfuSystem Holdings (INFU) reported Gross Margin of 58.43% for Q1 2026, up 322.0% on a YoY basis from 13.85% in Q1 2025, and up 3.6% quarter-over-quarter from 56.4% in Q4 2025.

InfuSystem Holdings (INFU) Gross Margin (2010 - 2026) Analysis & Trends

InfuSystem Holdings has reported Gross Margin for 17 years, with the latest figure at 58.43% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 322.0% year-over-year to 58.43%; the trailing twelve-month figure through Mar 2026 stood at 56.75% (up 362.0% YoY), and the FY2025 full-year result was 55.98%, up 378.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 58.43%, up from 56.4% in the prior quarter.
  • The five-year high for Gross Margin was 59.46% in Q3 2022, with the low at 48.81% in Q4 2022.
  • Historically, Gross Margin has averaged 53.67% across 5 years, with a median of 53.92% in 2024.
  • Annual changes were most pronounced in 2023 — Gross Margin sank 1052 bps — and 2025, when it soared 574 bps.
  • InfuSystem Holdings' Gross Margin stood at 48.81% in 2022, then climbed by 8 bps to 52.6% in 2023, then gained by 2 bps to 53.82% in 2024, then grew by 5 bps to 56.4% in 2025, then climbed by 4 bps to 58.43% in 2026.
  • The last three Gross Margin figures came in at 58.43% (Q1 2026), 56.4% (Q4 2025), and 57.06% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 56.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 63.29%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 63.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 38.53%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 43.89%
10 InfuSystem Holdings 189.78 Mn 187.68 Mn 19.68 Mn 58.43%

Historic Data

Download Data
DateValue
Mar 31, 2026 58.43%
Dec 31, 2025 56.40%
Sep 30, 2025 57.06%
Jun 30, 2025 55.20%
Mar 31, 2025 55.21%
Dec 31, 2024 53.82%
Sep 30, 2024 53.92%
Jun 30, 2024 49.46%
Mar 31, 2024 51.49%
Dec 31, 2023 52.60%
Sep 30, 2023 48.94%
Jun 30, 2023 49.89%
Mar 31, 2023 49.23%
Dec 31, 2022 48.81%
Sep 30, 2022 59.46%
Jun 30, 2022 55.10%
Mar 31, 2022 57.42%
Dec 31, 2021 51.45%
Sep 30, 2021 57.43%
Jun 30, 2021 60.60%